• Dec 04, 2006 | Webcast

    Vitamin D and Kidney Disease

    Craig Langman, M.D., Stuart Sprague, D.O., Sharon Martin Moe, M.D., Mary B. Leonard, M.D., MSCE
    Investigation of Metabolic Bone Diseases, Metabolic Bone Diseases, Integrative Physiology of the Skeleton

    Role of Vitamin D Deficiency in Chronic Kidney Disease
    Stuart Sprague, D.O., Northwestern University, Evanston, Illinois, USA

    Paradoxical Effects of Active Vitamin D Analogue Agents in CKD/End Stage Kidney Disease
    L. Darryl Quarles, M.D., University of Kansas Medical Center, Kansas City, Kansas, USA

    Effects of Vitamin D and Analogues on Cardiovascular Events and Life Expectancy in Patients with CRF
    Sharon M. Moe, M.D., Indiana University School of Medicine, Indianapolis, Indiana, USA

    Management of Renal Osteodystrophy in Childhood
    Mary B. Leonard, M.D., MSCE, Children’s Hospital of Philadelphia, Philadelphia,
    Pennsylvania, USA

    Supported by educational grants from Eli Lilly and Company, Merck & Co., Inc., NPS Pharmaceuticals, The Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals and sanofi-aventis, US) and Immunodiagnostic Systems.

    Funding for this conference was made possible (in part) by Grant AR055036 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases and the Office of Dietary Supplements. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    Length: 85 minutes

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details